Show simple item record

dc.rights.licenseopenen_US
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorFOUSSARD, Ninon
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorROUAULT, Paul
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCORNUAULT, Lauriane
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorREYNAUD, Annabel
dc.contributor.authorBUYS, Emmanuel S
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCHAPOULY, Candice
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorGADEAU, Alain-Pierre
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorCOUFFINHAL, Thierry
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorMOHAMMEDI, Kamel
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorRENAULT, Marie-Ange
dc.date.accessioned2025-03-18T17:20:16Z
dc.date.available2025-03-18T17:20:16Z
dc.date.issued2023-01-06
dc.identifier.issn1524-4571en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/205538
dc.description.abstractEnLower-limb peripheral artery disease is one of the major complications of diabetes. Peripheral artery disease is associated with poor limb and cardiovascular prognoses, along with a dramatic decrease in life expectancy. Despite major medical advances in the treatment of diabetes, a substantial therapeutic gap remains in the peripheral artery disease population. Praliciguat is an orally available sGC (soluble guanylate cyclase) stimulator that has been reported both preclinically and in early stage clinical trials to have favorable effects in metabolic and hemodynamic outcomes, suggesting that it may have a potential beneficial effect in peripheral artery disease. We evaluated the effect of praliciguat on hind limb ischemia recovery in a mouse model of type 2 diabetes. Hind limb ischemia was induced in leptin receptor-deficient (Lepr) mice by ligation and excision of the left femoral artery. Praliciguat (10 mg/kg/day) was administered in the diet starting 3 days before surgery. Twenty-eight days after surgery, ischemic foot perfusion and function parameters were better in praliciguat-treated mice than in vehicle controls. Improved ischemic foot perfusion was not associated with either improved traditional cardiovascular risk factors (ie, weight, glycemia) or increased angiogenesis. However, treatment with praliciguat significantly increased arteriole diameter, decreased ICAM1 (intercellular adhesion molecule 1) expression, and prevented the accumulation of oxidative proangiogenic and proinflammatory muscle fibers. While investigating the mechanism underlying the beneficial effects of praliciguat therapy, we found that praliciguat significantly downregulated and mRNA expression in cultured myoblasts and that conditioned medium form praliciguat-treated myoblast decreased mRNA expression in endothelial cells. These results suggest that praliciguat therapy may decrease expression in endothelial cells by downregulating in myocytes. Our results demonstrated that praliciguat promotes blood flow recovery in the ischemic muscle of mice with type 2 diabetes, at least in part by increasing arteriole diameter and by downregulating ICAM1 expression.
dc.language.isoENen_US
dc.subject.enMice
dc.subject.enAnimals
dc.subject.enDiabetes Mellitus
dc.subject.enType 2
dc.subject.enReceptors
dc.subject.enLeptin
dc.subject.enEndothelial Cells
dc.subject.enIschemia
dc.subject.enDisease Models
dc.subject.enAnimal
dc.subject.enReperfusion
dc.subject.enPeripheral Arterial Disease
dc.subject.enHindlimb
dc.subject.enNeovascularization
dc.subject.enPhysiologic
dc.subject.enMuscle
dc.subject.enSkeletal
dc.subject.enMice
dc.subject.enInbred C57BL
dc.title.enPraliciguat Promotes Ischemic Leg Reperfusion in Leptin Receptor-Deficient Mice.
dc.title.alternativeCirc Resen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1161/CIRCRESAHA.122.322033en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed36448444en_US
bordeaux.journalCirculation Researchen_US
bordeaux.page34-48en_US
bordeaux.volume132en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires (BMC) - UMR 1034en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-04996210
hal.version1
hal.date.transferred2025-03-18T17:20:18Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Circulation%20Research&rft.date=2023-01-06&rft.volume=132&rft.issue=1&rft.spage=34-48&rft.epage=34-48&rft.eissn=1524-4571&rft.issn=1524-4571&rft.au=FOUSSARD,%20Ninon&ROUAULT,%20Paul&CORNUAULT,%20Lauriane&REYNAUD,%20Annabel&BUYS,%20Emmanuel%20S&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record